Home/Lomond Therapeutics/Fraser Pickersgill
FP

Fraser Pickersgill

Head CMC

Lomond Therapeutics

Therapeutic Areas

Lomond Therapeutics Pipeline

DrugIndicationPhase
lomonitinibAcute Myeloid Leukemia (AML)IND-Enabling
lonitoclaxChronic Lymphocytic Leukemia (CLL)Phase 1
Menin InhibitorAcute Myeloid Leukemia (AML)Discovery